# Oral semaglutide versus injectable glucagon-like peptide-1 receptor agonists: a cost of control analysis

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/oral-semaglutide-versus-injectable-glucagon-like-peptide-1-receptor-agonists-a/

## Facts

| Field | Value |
| --- | --- |
| Author Names | B.B. Hansen,Solomon Nuhoho,Sarah Ali,Tam Dang‐Tan,William J. Valentine,Samuel J. P. Malkin,Barnaby Hunt |
| Citations | 35 |
| DOI | 10.1080/13696998.2020.1722678 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://www.tandfonline.com/doi/pdf/10.1080/13696998.2020.1722678?needAccess=true |
| OpenAlex ID | https://openalex.org/W3003534791 |
| PMID | 31990244 |
| Type | article |
| Year | 2020 |

## Paper authors

- [Sarah Ali](https://scholariq.org/researchers/sarah-ali/)

## Paper journal

- [Journal of Medical Economics](https://scholariq.org/journals/journal-of-medical-economics/)

## Paper primary topic

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)

## Paper topics

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Metabolism, Diabetes, and Cancer](https://scholariq.org/topics/metabolism-diabetes-and-cancer/)
- [Diabetes Management and Research](https://scholariq.org/topics/diabetes-management-and-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.